{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:44:53Z","timestamp":1791247493244,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":732,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Abbot"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.rmed.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T18:43:34Z","timestamp":1553021014000},"page":"149-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Long term follow-up of Palivizumab administration in children born at 29\u201332 weeks of gestation"],"prefix":"10.1016","volume":"150","author":[{"given":"Ronen","family":"Bar-Yoseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monnera","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Kugelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahed","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-5415","authenticated-orcid":false,"given":"Lea","family":"Bentur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.03.001_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(99)80040-3","article-title":"Respiratory syncytial virus infection","volume":"354","author":"Simoes","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.03.001_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","article-title":"Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7","volume":"161","author":"Sigurs","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.95.4.500","article-title":"Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls","volume":"95","author":"Sigurs","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmed.2019.03.001_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1651-2227.2000.tb00359.x","article-title":"Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review","volume":"89","author":"Kneyber","year":"2000","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.rmed.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ppul.20058","article-title":"Respiratory morbidity 20 years after RSV infection in infancy","volume":"38","author":"Korppi","year":"2004","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1086\/386372","article-title":"Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice","volume":"189","author":"Jafri","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.rmed.2019.03.001_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1164\/ajrccm.156.1.9611050","article-title":"Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response","volume":"156","author":"Rom\u00e1n","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1542\/peds.102.5.1211","article-title":"Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmed.2019.03.001_bib11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2007.02.032","article-title":"Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing","volume":"151","author":"Simoes","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.rmed.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2010.05.026","article-title":"The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children","volume":"126","author":"Sim\u00f5es","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S2213-2600(18)30055-9","article-title":"Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial","volume":"6","author":"Scheltema","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2019.03.001_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1164\/rccm.201609-1812OC","article-title":"Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing: six-year follow-up study","volume":"196","author":"Mochizuki","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-152-4-201002160-00008","article-title":"Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes","volume":"152","author":"Levine","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2731","article-title":"Innate and adaptive immune responses in asthma","volume":"18","author":"Holgate","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/rccm.200605-642ST","article-title":"An official American thoracic society\/European respiratory society statement: pulmonary function testing in preschool children","volume":"175","author":"Beydon","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/CRIAI:24:1:19","article-title":"Bronchoprovocation methods: direct challenges","volume":"24","author":"Cockcroft","year":"2003","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.rmed.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ppul.20978","article-title":"The potential use of spirometry during methacholine challenge test in young children with respiratory symptoms","volume":"44","author":"Vilozni","year":"2009","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2019.03.001_bib21","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"Standardization of spirometry: 1994 update","volume":"152","author":"Crapo","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib22","first-page":"309","article-title":"Guidelines for methacholine and exercise challenge testing - 1999","volume":"161","author":"Crapo","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4168\/aair.2016.8.1.12","article-title":"Exhaled NO: determinants and clinical application in children with allergic airway disease","volume":"8","author":"Kim","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.rmed.2019.03.001_bib24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.15-0328","article-title":"Short-and long-term pulmonary outcome of palivizumab in children born extremely prematurely","volume":"149","author":"Prais","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.03.001_bib26","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.rmed.2007.07.002","article-title":"Methacholine challenge in pre-school children-Which outcome measure?","volume":"101","author":"Kivastik","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/v5030777","article-title":"Th17 lymphocytes in respiratory syncytial virus infection","volume":"5","author":"Bystrom","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.rmed.2019.03.001_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/INF.0b013e3181a3ea71","article-title":"Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus","volume":"28","author":"Larranaga","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.rmed.2019.03.001_bib29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jmv.23291","article-title":"Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis","volume":"84","author":"Faber","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.rmed.2019.03.001_bib30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1164\/rccm.200904-0573OC","article-title":"Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness","volume":"180","author":"Wilson","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.03.001_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000250438","article-title":"Th17 immunity in patients with allergic asthma","volume":"151","author":"Zhao","year":"2010","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:55:06Z","timestamp":1760615706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119300721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":31,"alternative-id":["S0954611119300721"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.03.001","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term follow-up of Palivizumab administration in children born at 29\u201332 weeks of gestation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}